Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Comment by runmyownlifeon May 17, 2019 1:23pm
132 Views
Post# 29756294

RE:RE:RE:RE:Reality Check

RE:RE:RE:RE:Reality Check
It only took 110,000 shares to cause the 40% drop. That's an indication of too few interested buyers rather than an indictment of the financial situation. I'd argue management's seemingly perpetual slow execution, particularly in sales and market development, along with very limited promotion are greater cause for concern than the court case. Executive renumeration should be more tightly tied to sales and revenue performance.....
<< Previous
Bullboard Posts
Next >>